WallStreetZenWallStreetZen

NASDAQ: BRNS
Barinthus Biotherapeutics PLC Earnings & Revenue

BRNS past revenue growth

How has BRNS's revenue growth performed historically?
Company
-98.21%
Industry
165.61%
Market
17.84%
BRNS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BRNS's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance

BRNS earnings and revenue history

Current Revenue
$802.0k
Current Earnings
-$73.3M
Current Profit Margin
-9,145.5%

BRNS Return on Equity

Current Company
-35.2%
Current Industry
-63.6%
Current Market
188%
BRNS's Return on Equity (-35.2%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BRNS announces earnings.

BRNS Return on Assets

Current Company
-30.8%
Current Industry
3%
BRNS is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BRNS Return on Capital Employed

Current Company
-37.84%
Current Industry
19.6%
BRNS's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BRNS vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BRNS$802.00k-$69.64M-$73.35M-41.49%N/A
SPRO$103.78M$25.77M$22.81M+92.11%N/A
PLX$65.49M$11.65M$8.31M+13.85%N/A
CUE$5.49M-$46.05M-$50.73M+36.88%N/A
CARM$10.63M-$67.76M-$73.50M-37.78%N/A

BRNS earnings dates

Next earnings date
May 10, 2024

Barinthus Biotherapeutics Earnings & Revenue FAQ

What were BRNS's earnings last quarter?

On Invalid Date, Barinthus Biotherapeutics (NASDAQ: BRNS) reported Q4 2023 earnings per share (EPS) of -$0.45, up 21.05% year over year. Total Barinthus Biotherapeutics earnings for the quarter were -$17.29 million. In the same quarter last year, Barinthus Biotherapeutics's earnings per share (EPS) was -$0.57.

If you're new to stock investing, here's how to buy Barinthus Biotherapeutics stock.

What was BRNS's earnings growth in the past year?

As of Q1 2024, Barinthus Biotherapeutics's earnings has grown year over year. Barinthus Biotherapeutics's earnings in the past year totalled -$73.35 million.

What is BRNS's earnings date?

Barinthus Biotherapeutics's earnings date is Invalid Date. Add BRNS to your watchlist to be reminded of BRNS's next earnings announcement.

What was BRNS's revenue last quarter?

On Invalid Date, Barinthus Biotherapeutics (NASDAQ: BRNS) reported Q4 2023 revenue of $0.00 up 100% year over year. In the same quarter last year, Barinthus Biotherapeutics's revenue was $6.46 million.

What was BRNS's revenue growth in the past year?

As of Q1 2024, Barinthus Biotherapeutics's revenue has grown -98.21% year over year. This is 263.82 percentage points lower than the US Biotechnology industry revenue growth rate of 165.61%. Barinthus Biotherapeutics's revenue in the past year totalled $802.00 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.